View Author
scopus: 22734126700

Hambrock, T.

(Thomas Hambrock)


biopsy prostate cancer gleason dutasteride imaging patient mr-gb prostate cancer trusbx prostate-speci fic antigen tumour study value detection performance antigen grade prostate cancer detection cohort undergrading urology prostatectomy van leeuwen pj european region trial volume aggressiveness performance rates table 10- core trusbx psa values van leeuwen resonance leeuwen increase 7–10 gleason grades tumours analysis serum hambrock 10- treatment serum psa prostate-specific antigen diffusion diagnosis resonance imaging centre diffusion coef ficient diffusion-weighted imaging biopsied radboud university nijmegen score difference assessment andriole range transition zone transrectal pretreatment assessment reduction utility diffusion-weighted article result prostate-speci dutasteride treatment gleason grade press pathology follow-up prostate needle biopsy ef ficacy population –guided needle gleason 7–10 pca nijmegen




2 Most Recent Publications

Prospective assessment of prostate cancer aggressiveness using 3-T diffusion-weighted magnetic resonance imaging-guided biopsies versus a systematic 10-core transrectal ultrasound prostate biopsy cohort (Article)
Hambrock, T. Hoeks, C. Hulsbergen-Van de Kaa, C.A. Scheenen, T. Fütterer, J. Bouwense, S. Oort, I.M. van Schröder, F.H. Huisman, H. Barentsz, J.
2012-01-01
Prostate Cancer Detection and Dutasteride: Utility and Limitations of Prostate-Specific Antigen in Men with Previous Negative Biopsies (Article)
Leeuwen, P.J. van Kölble, K. Huland, H. Hambrock, T. Barentsz, J. Schröder, F.H.
2010-01-01